taking semaglutide and tirzepatide Maintenance therapy on or Semaglutide Or Tirzepatide: Which Weight

If symptoms persist beyond 4 weeks or worsen over time, contact your healthcare provider

The efficacy of oral semaglutide in reducing glycated hemoglobin (HbA 1c ) and body weight in individuals with T2D has been demonstrated in the phase 3 PIONEER 9 and 10 clinical trials [3, 4]

GLP-1 receptor agonist drugs are specifically engineered to mimic the activity of the natural GLP-1 hormone and provide sustained activation of GLP-1 receptors

After weight loss, some patients experience stubborn fat pockets or mild skin laxity

The medication works by mimicking two natural hormones: GLP-1 increases fullness, and GIP enhances insulin sensitivity

S.FrayoR